nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study
|
Zullo, A. R. |
|
|
32 |
3 |
p. 565-573 |
artikel |
2 |
Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis
|
de Vries, B. C. S. |
|
|
32 |
3 |
p. 437-449 |
artikel |
3 |
Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture
|
Lane, N. E. |
|
|
32 |
3 |
p. 609 |
artikel |
4 |
Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
|
Hiligsmann, M. |
|
|
32 |
3 |
p. 595-606 |
artikel |
5 |
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
|
Söreskog, E. |
|
|
32 |
3 |
p. 585-594 |
artikel |
6 |
C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches
|
Mun, H. |
|
|
32 |
3 |
p. 425-435 |
artikel |
7 |
Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome
|
Hong, N. |
|
|
32 |
3 |
p. 483-493 |
artikel |
8 |
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
|
Rosenberg, D. |
|
|
32 |
3 |
p. 413-424 |
artikel |
9 |
Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling
|
Winzenrieth, R. |
|
|
32 |
3 |
p. 575-583 |
artikel |
10 |
Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial
|
Osaki, M. |
|
|
32 |
3 |
p. 495-503 |
artikel |
11 |
Exploring thoracic kyphosis and incident fracture from vertebral morphology with high-intensity exercise in middle-aged and older men with osteopenia and osteoporosis: a secondary analysis of the LIFTMOR-M trial
|
Harding, A. T. |
|
|
32 |
3 |
p. 451-465 |
artikel |
12 |
Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients
|
Vehmanen, L. |
|
|
32 |
3 |
p. 473-482 |
artikel |
13 |
FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture
|
Sagalla, N. |
|
|
32 |
3 |
p. 467-472 |
artikel |
14 |
Functional electrical stimulation (FES)–assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury
|
Fang, Y. |
|
|
32 |
3 |
p. 549-558 |
artikel |
15 |
Incidence and circumstances of falls among middle-aged women: a cohort study
|
Wang, M. |
|
|
32 |
3 |
p. 505-513 |
artikel |
16 |
In memory of Harry K Genant
|
Cooper, C. |
|
|
32 |
3 |
p. 607-608 |
artikel |
17 |
Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort
|
Lee, J.W. |
|
|
32 |
3 |
p. 529-538 |
artikel |
18 |
Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women
|
Smith, L. M. |
|
|
32 |
3 |
p. 539-547 |
artikel |
19 |
Sleep duration and bone health measures in older men
|
Swanson, C. M. |
|
|
32 |
3 |
p. 515-527 |
artikel |
20 |
Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture
|
Zhu, K. |
|
|
32 |
3 |
p. 559-564 |
artikel |
21 |
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services
|
Lems, W. F. |
|
|
32 |
3 |
p. 399-411 |
artikel |